General Catalyst Group Management, LLC
- SEC CIK
- 0001637946
- Latest filing
- Aug 14, 2026
ODTX holding history
Odyssey Therapeutics, Inc. in every 13F filed by General Catalyst Group Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ODTX overviewAll 13F holders of ODTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 810,272
- Value
- $15.2M
- % of portfolio
- 8.0%
- Quarters held
- 1
- Since Q2 2026